ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

APLM Apollomics Inc

0.41
0.00 (0.00%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Apollomics Inc APLM NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.41 23:00:04
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.4074 0.388 0.4386 0.3965 0.41
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202407:30GLOBEApollomics Announces Approval of Vebreltinib in China as a..
10/4/202406:00GLOBEApollomics Presents Vebreltinib Data at the 2024 American..
02/4/202407:00GLOBEApollomics Announces Poster Presentations of Vebreltinib..
28/3/202406:00GLOBEApollomics Highlights Clinical Progress and Reports Full..
26/3/202407:00GLOBEApollomics to Announce Full Year 2023 Financial Results and..
04/3/202406:00GLOBEApollomics Appoints Matthew Plunkett, Ph.D. as Chief..
07/2/202406:00GLOBEApollomics to Present at the Oppenheimer 34th Annual..
19/1/202415:15GLOBEApollomics Receives Nasdaq Notification Regarding Minimum..
17/1/202415:30GLOBEApollomics to Participate in a Fireside Chat at the B. Riley..
03/1/202406:00GLOBEApollomics Completes Enrollment in Phase 3 Bridging Study of..
02/1/202415:30GLOBEApollomics to Present at the 2024 Biotech Showcase
04/12/202306:00GLOBEApollomics Presents Interim Data from Two Ongoing Phase 2..
29/11/202306:30GLOBEApollomics to Participate in a Fireside Chat at the H.C...
28/11/202306:00GLOBEApollomics Announces Presentation of Vebreltinib Data at the..
16/11/202307:30GLOBEApollomics Announces the First Approval of Vebreltinib for..
31/10/202307:30GLOBEApollomics Announces Two New Cohorts in Global Phase 2..
26/10/202307:50GLOBEApollomics Announces Report of Activity of Vebreltinib in..
23/10/202307:30GLOBEApollomics Announces Efficacy of Vebreltinib in NSCLC..
16/10/202317:55GLOBEApollomics Announces Presentations of Vebreltinib Data at..
28/9/202315:17GLOBEApollomics Reports First Half 2023 Financial Results and..
06/9/202306:00GLOBEApollomics to Present at the H.C. Wainwright 25th Annual..

Su Consulta Reciente

Delayed Upgrade Clock